Correlation Between Caribou Biosciences and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Apellis Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and Apellis Pharmaceuticals
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Caribou and Apellis is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Apellis Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Caribou Biosciences is 1.24 times more volatile than Apellis Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 4,756 in Apellis Pharmaceuticals on September 26, 2024 and sell it today you would lose (1,424) from holding Apellis Pharmaceuticals or give up 29.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Apellis Pharmaceuticals
Performance |
Timeline |
Caribou Biosciences |
Apellis Pharmaceuticals |
Caribou Biosciences and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Apellis Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Apellis Pharmaceuticals vs. Fate Therapeutics | Apellis Pharmaceuticals vs. Caribou Biosciences | Apellis Pharmaceuticals vs. Karyopharm Therapeutics | Apellis Pharmaceuticals vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |